Commercialization: Page 19
-
PharmaVoice Team/PharmaVoice
The Power of Patients
Patient engagement is permeating all spheres of the healthcare ecosystem. On the cover… This month’s cover image is a self-portrait painted by Casey Ford, age 19, who has a rare connective tissue disorder, which is characterized by under-developed, absent, or misplaced/misaligned kneecaps in newb...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Gallery
Last year, we were honored to feature the art work of Max Schill, now 11, who remains an active patient advocate, and who helped pass the 21st Century Cure Act. We are excited to continue this tradition with this year’s original artwork by 19-year-old Casey Ford. To expand the patient gallery we ...
By Robin Robinson • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Driving Patient Engagement
A cultural shift throughout pharma is putting patients squarely in the middle of strategic decision-making. Pharmaceutical companies should take a cue from patient advocacy groups to drive patient engagement, and even partner with those advocacy organizations to create better patient experiences ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient-Enhanced Drug Discovery and Development
Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In other industries, it would seem odd not to get input from the end user of a product throughout the development stages. But it seems that pharmaceutical companies — some ...
By Taren Grom • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Relationships: Physicians and Payers
Patients are taking an active role in developing relationships with all stakeholders within their healthcare environment. Over the past several years, the relationship between pharma companies and patients has garnered much of the industry’s attention. But as patients become more empowered, engag...
By Robin Robinson • March 1, 2020 -
PharmaVoice Team/PharmaVoice
A Different Kind of Real-World Evidence: The Key Role That Patient-Provider Dialogue Research Can Play
All roads in healthcare lead to and from the medical visit. Well, maybe not all roads, but nearly all. The medical visit is central to the overarching healthcare structure and it is driven by the dialogue between patient and provider. The healthcare data and research landscape has been changing s...
By Katy Hewett • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Patient Heroes
The definition of a hero is a person who is admired for courage, outstanding achievements, or noble qualities. There is a massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026. Patient needs are not only supported by...
By PharmaVoice Team • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Making the Patient an Extension of the Team
The concept of patient-centricity is well embedded throughout EVERSANA and is intrinsically tied to helping the agency’s clients achieve their goals. Kristin LaBounty Phillips believes that the entire agency — with a unified commitment to quality in addressing patients’ needs — embodies the conce...
By Kristin LaBounty Phillips • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Breaking Down Barriers to Bring Patients Equal Access to Top-Quality Care
Patients Always The term “patients first" is not enough, rather it’s “patients always" because patients are our North Star through every stage of development — from discovery to clinical trials to approved treatment. Eve Dryer Executive Director, Patient Advocacy Retrophin All patients should hav...
By Eve Dryer • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Clinical Educators Provide Support Along the Whole Patient Journey
Team Power The teams of clinical educators at VMS BioMarketing are driven to help patients on a one-to-one basis to manage chronic illnesses — in the field or on the phone each day. Taking A Step-Wise Approach to clinical education There is one club that no one wants to join, but for those who wo...
By Clinical Educator Teams • March 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
Mylan’s Team in Turkey is Helping Women and Children More than a dozen members of Mylan Turkey recently traveled to Mardin to help open a new toy library at the Cumhuriyet Neighborhood Women-Children Center. Mylan supported the project with the Foundation for the Support of Women’s Work (KEDV) to...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Newly FDA-Approved Ingestible Pill Challenges Struggling Proteus Trend Watch: From ingestibles to implants, medical devices continue to create healthcare solutions The FDA approved an ingestible event marker from the privately held digital health company etectRx. The Florida-based company said th...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
AI Tech Company Partners with Roche for Clinical Trial Work Trend Watch: Adoption of AI in Pharma Continues to Grow Sensyne Health signed its second successive partnership with a major pharmaceutical company at the end of 2019 when it agreed to collaborate with Roche to focus on identifying patie...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Agile Marketing
Agile allows agencies to move twice as fast with more favorable outcomes. Agency marketers are very accustomed to putting out fires, juggling tasks, as well as hats, and wading their way through daily chaos as they attempt to create successful campaigns for clients. According to our experts, ther...
By Robin Robinson • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
R&D INFLUENCER: Dr. Joanne Santomauro — Ancillere LP
Tackling Ancillary Supply Challenges with Innovative Solutions When a pharmaceutical client came to Joanne Santomauro nearly 15 years ago with a request to help with a complex and expensive ancillary supply challenge, she didn’t hesitate. She launched Ancillare and began the journey to create and...
By Dr. Joanne Santomauro • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Oncology Market Insights
Analysts and experts discuss scientific, technological, and access advancements in the oncology area. Oncology clinical development activities are being undertaken by more than 700 companies and are at record high levels, according a report by the IQVIA Institute for Human Data Science. But despi...
By PharmaVoice Team • Feb. 1, 2020 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a busines...
By Taren Grom • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Upfront
GSK Offers Grants to Nonprofits Making an IMPACT on Health Outcomes GlaxoSmithKline has honored 10 Philadelphia nonprofit organizations that offer youth mentoring, housing, legal aid, education, and other critical services that help foster a healthier region. The 10 winners of the GSK IMPACT Awar...
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
HealthTech
Astellas and Welldoc Pair Up for Digital Therapeutics Trend Watch: Pharma’s Use of Healthtech Continues to Gain Ground Astellas Pharma and Welldoc have entered into a collaboration and license agreement directed toward the development and commercialization of digital health solutions. Under the a...
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Cyclica and ATAI Partner to Develop Drugs to Treat Mental Health Trend Watch: Partnerships Leverage AI for Drug Discovery and Development Cyclica, an artificial intelligence-powered biotechnology company, has partnered with the biotech company ATAI Life Sciences to create Entheogenix Biosciences....
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: High-Science Brands: Making Connections for High Science Brands
The growth of high-science brands has changed the life sciences landscape, and with it the strategies companies need to develop to market their products must also undergo a significant shift. Cancer immunotherapies as well as other high-science brands will account for $34 billion in sales by 2024...
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Facts Tell, Stories Sell
People hear facts, but feel stories, and medical storytelling today is a winning combination of both. In 2013, Novartis broke the mold in marketing with its campaign for its oral multiple sclerosis treatment Gilenya. The campaign, “Hey MS, Take This!" shows various patients sticking out their ton...
By Robin Robinson • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Virtual Health: Exploring the Potential of Virtual Health
As healthcare costs continue to spiral, the need to find effective ways to balance the demands of an aging population becomes more pressing. One approach that has the potential to make a significant difference is virtual health, which allows patients with chronic diseases to be monitored more eff...
By PharmaVoice Team • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Wear it on Your Sleeve — How Sensors and Wearables Help Drive Richer Insights on Intervention Effects
“I didn’t sleep well last night." It’s a phrase we’ve all heard, and unfortunately said, hundreds if not thousands of times. For some of us, the phrase instantly invokes the struggles to fall asleep, tossing and turning throughout the night. For others it means constantly waking up, gaining only ...
By Bill Byrom • Jan. 1, 2020 -
PharmaVoice Team/PharmaVoice
Unraveling Data Ownership
Amid ongoing concerns over data privacy and how patients’ data is used, who owns the data is both a crucial and complex question. Just who owns a patient’s data? It’s a question that is fraught with complications due to the sensitive nature of the information. Data has been described as the most ...
By Kim Ribbink • Jan. 1, 2020
Previous
